Non-alcoholic fatty liver disease (NAFLD) has gradually become one of the major liver
health problems in the world. The dynamic course of the disease goes through steatosis …

Non-alcoholic fatty liver disease (NAFLD) exhibits increased lipid enrichment in
hepatocytes. The spectrum of this disease includes stages such as nonalcoholic simple fatty …

Copper‐based nanozymes exhibit excellent antitumor activity but are easily inactivated due
to the disturbance of proteins or other macromolecules with sulfhydryl. A tumor …

Nonalcoholic steatohepatitis (NASH) is prevalent in the global population, where up to one-
third of patients would further progress to developing fibrosis, cirrhosis, and hepatocellular …

The most common chronic liver illness, non-alcoholic fatty liver disease (NAFLD), refers to a
range of abnormalities of the liver with varying degrees of steatosis. When the clinical …

Enzymatic activity is a pivotal factor in cancer progression, necessitating the development of
in vivo imaging techniques for precise enzyme localization and quantification within tumors …

Liver fibrosis is the critical stage in the development of chronic liver disease (CLD), from
simple injury to irreversible cirrhosis. Timely detection and intervention of liver fibrosis are …

Neutrophil extracellular traps (NETs) severely affect tumor metastasis through a self-
perpetuating feedback loop involving two key steps:(1) mitochondrial aerobic respiration …

Personalized radiotherapy strategies enabled by the construction of hypoxia‐guided
biological target volumes (BTVs) can overcome hypoxia‐induced radioresistance by …

Contrast agents (CAs) enhanced magnetic resonance imaging (MRI) are potential
candidates for the effective diagnosis of glioblastoma (GBM). However, the invasiveness …